-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Ironwood Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from 2017 to Q1 2025.
- Ironwood Pharmaceuticals Inc Depreciation for the quarter ending March 31, 2025 was $479K, a 6.63% decline year-over-year.
- Ironwood Pharmaceuticals Inc annual Depreciation for 2024 was $2.01M, a 27.7% increase from 2023.
- Ironwood Pharmaceuticals Inc annual Depreciation for 2023 was $1.58M, a 11.1% increase from 2022.
- Ironwood Pharmaceuticals Inc annual Depreciation for 2022 was $1.42M, a 6.89% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)